SV / EN

Articles by Thomas Hedner

CRISPR/Cas9 system and gene editing tools – On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine

Thomas Hedner , Jean Lycke

Published in Stockholm IP Law Review 2019 #1, June 2019 s. 12–23

Direct links